Nukkleus (NASDAQ:NUKK) Shares Down 10.1% – Time to Sell?

Nukkleus Inc. (NASDAQ:NUKKGet Free Report) shares fell 10.1% on Monday . The company traded as low as $16.50 and last traded at $18.00. 355,335 shares traded hands during mid-day trading, a decline of 75% from the average session volume of 1,396,463 shares. The stock had previously closed at $20.02.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen downgraded Nukkleus from a “hold” rating to a “sell” rating in a research report on Thursday, May 22nd.

View Our Latest Report on NUKK

Nukkleus Stock Performance

The business has a 50-day moving average price of $14.96 and a 200 day moving average price of $16.31.

Nukkleus (NASDAQ:NUKKGet Free Report) last announced its quarterly earnings data on Friday, May 23rd. The company reported $18.19 EPS for the quarter.

Institutional Investors Weigh In On Nukkleus

An institutional investor recently bought a new position in Nukkleus stock. Compagnie Lombard Odier SCmA acquired a new stake in shares of Nukkleus Inc. (NASDAQ:NUKKFree Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 6,200 shares of the company’s stock, valued at approximately $74,000. Compagnie Lombard Odier SCmA owned about 0.13% of Nukkleus as of its most recent filing with the Securities and Exchange Commission. 12.47% of the stock is currently owned by hedge funds and other institutional investors.

Nukkleus Company Profile

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors.

See Also

Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.